{"disease":{"id":"neoplasms-endometrial","name":"neoplasms endometrial"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00341458","title":"Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics","phase":"","overall_status":"COMPLETED","enrollment_count":6086,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07298707","title":"Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03291106","title":"Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT07015593","title":"Patient Journey in Advanced Gynecologic Cancers","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":780,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05208762","title":"A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":714,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT03935282","title":"Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors","phase":"NA","overall_status":"COMPLETED","enrollment_count":645,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT05007106","title":"MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":613,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT07286331","title":"A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-Endometrial01)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01631552","title":"Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":515,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03207061","title":"Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer?","phase":"NA","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT05793749","title":"Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Chongqing University Cancer Hospital","has_results":false},{"nct_id":"NCT04104776","title":"A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":275,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05194072","title":"A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":250,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT02632448","title":"A Study of LY2880070 in Participants With Advanced or Metastatic Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"Esperas Pharma Inc.","has_results":false},{"nct_id":"NCT06023862","title":"A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":198,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT05180474","title":"GEN1047 for Solid Tumors - First in Human (FIH) Trial","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":179,"lead_sponsor_name":"Genmab","has_results":false},{"nct_id":"NCT06751329","title":"A Study of DM002 in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Xadcera Biopharmaceutical (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT03207074","title":"Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT07038369","title":"A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":134,"lead_sponsor_name":"Atavistik Bio, Inc","has_results":false},{"nct_id":"NCT06003231","title":"A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT04665921","title":"A Study of SGN-STNV in Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":111,"lead_sponsor_name":"Seagen Inc.","has_results":false},{"nct_id":"NCT06521684","title":"Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04295109","title":"Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function","phase":"NA","overall_status":"UNKNOWN","enrollment_count":105,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT04972682","title":"[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Moscow City Oncology Hospital No. 62","has_results":false},{"nct_id":"NCT06897527","title":"A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT07040657","title":"Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Dokuz Eylul University","has_results":false},{"nct_id":"NCT05316935","title":"GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Xiaojun Chen","has_results":false},{"nct_id":"NCT05001282","title":"A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":79,"lead_sponsor_name":"Elucida Oncology","has_results":false},{"nct_id":"NCT03595722","title":"Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT05945407","title":"Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":57,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04870177","title":"Study of AK112 in the Treatment of Advanced Gynecological Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"Akeso","has_results":false},{"nct_id":"NCT04660929","title":"CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Carisma Therapeutics Inc","has_results":false},{"nct_id":"NCT05229900","title":"A Study of SGN-ALPV in Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Seagen Inc.","has_results":false},{"nct_id":"NCT01717391","title":"[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"John M. Buatti","has_results":true},{"nct_id":"NCT07108270","title":"A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT05067972","title":"A Study of PF-07260437 in Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":30,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06379113","title":"GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":29,"lead_sponsor_name":"Xiaojun Chen","has_results":false},{"nct_id":"NCT06620029","title":"BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":27,"lead_sponsor_name":"BioMimetix JV, LLC","has_results":false},{"nct_id":"NCT06264921","title":"A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":23,"lead_sponsor_name":"NiKang Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02900248","title":"CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice","phase":"","overall_status":"TERMINATED","enrollment_count":23,"lead_sponsor_name":"CureOne","has_results":false},{"nct_id":"NCT06466187","title":"A Study of SGN-MesoC2 in Advanced Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":19,"lead_sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT04995809","title":"Effect of Pelvic Radiotherapy on the Intestinal Microbiome and Metabolome","phase":"","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"The Christie NHS Foundation Trust","has_results":false},{"nct_id":"NCT06710847","title":"A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":14,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03207126","title":"Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT02630823","title":"MK-3475 Immunotherapy in Endometrial Carcinoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Washington University School of Medicine","has_results":true}],"total":45},"guidelines":[],"source":"Drug Landscape verified database"}